Company / Interest Expense per Share
Perspective Therapeutics, Inc. Interest Expense per Share History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
-
FY2022
5-year range
$0.00 / $0.00
FY2018-FY2022
Trend
-
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.00 to $0.00 over the past 5 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Peak interest expense per share was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0.00 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $0.00 | -50.0% |
| FY2017 | $0.00 | +71.0% |
| FY2016 | $0.00 | +12514.3% |
| FY2015 | $0.00 | - |
| FY2014 | - | - |
| FY2013 | - | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026